TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bioglan AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
228,470
|
171,411
|
157,335 |
Financial expenses |
925
|
760
|
850 |
Earnings before taxes |
30,080
|
10,011
|
12,258 |
EBITDA |
37,452
|
15,546
|
16,443 |
Total assets |
232,213
|
178,632
|
136,467 |
Current assets |
150,573
|
115,206
|
105,963 |
Current liabilities |
96,648
|
73,969
|
35,084 |
Equity capital |
135,565
|
104,662
|
99,784 |
- share capital |
3,039
|
2,838
|
2,926 |
Employees (average) |
102
|
101
|
94 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
58.4%
|
58.6%
|
73.1% |
Turnover per employee |
2,240
|
1,697
|
1,674 |
Profit as a percentage of turnover |
13.2%
|
5.8%
|
7.8% |
Return on assets (ROA) |
13.4%
|
6.0%
|
9.6% |
Current ratio |
155.8%
|
155.7%
|
302.0% |
Return on equity (ROE) |
22.2%
|
9.6%
|
12.3% |
Change turnover |
44,897
|
18,805
|
-12,334 |
Change turnover % |
24%
|
12%
|
-7% |
Chg. No. of employees |
1
|
7
![]() |
7 |
Chg. No. of employees % |
1%
|
7%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.